Stockreport

Cogent Biosciences Touts Bezuclastinib Pivotal Wins, Eyes Up to Three FDA Filings and U.S. Launches [Yahoo! Finance]

Cogent Biosciences, Inc.  (COGT) 
Last cogent biosciences, inc. earnings: 11/8 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.cogint.com/investor-relations
PDF systemic mastocytosis, plus GIST), and Cogent is preparing parallel NDA submissions with potential U.S. launches in one to all three indications depending on FDA review, [Read more]